OMERACT 2023 系统性红斑狼疮特别兴趣小组:为核心结局集初步筛选与归类候选领域
在OMERACT 2023会议上,系统性红斑狼疮工作组通过特别兴趣小组及后续虚拟会议,对定性研究和文献综述产生的132个领域子主题进行筛选与归类,最终基于临床和研究相关性将其缩减为20个候选领域的初步清单,为后续SLE核心结局集的共识德尔菲流程做准备。
要点
- 132个领域子主题经筛选归类后形成20个候选领域初步清单。
- 筛选依据为候选领域对临床试验和研究的临床与研究相关性。
- 该清单将进入SLE核心结局集的共识德尔菲流程。
核心结论
- 对SLE核心结局集候选领域实现了有意义且实质性的筛选与归类,形成包含20个候选领域的初步清单。
研究设计与样本
- 在OMERACT 2023会议(科罗拉多斯普林斯)的SLE特别兴趣小组中设四个分组进行筛选归类,并由SLE患者研究伙伴、OMERACT SLE工作组指导委员会成员及其他合作者组成的咨询组通过系列虚拟会议继续推进。
主要发现
- 132个领域子主题被缩减为20个候选领域的初步清单。
关键数值与推荐
- 候选领域的筛选与归类基于其对临床试验和研究的临床与研究相关性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Outcome Measures in Rheumatology (OMERACT) Systemic Lupus Erythematosus (SLE) Working Group held a Special Interest Group (SIG) at the OMERACT 2023 conference in Colorado Springs where SLE collaborators reviewed domain sub-themes generated through qualitative research and literature review. OBJECTIVE: The objective of the SIG and the subsequent meetings of the SLE Working Group was to begin the winnowing and binning of candidate domain sub-themes into a preliminary list of candidate domains that will proceed to the consensus Delphi exercise for the SLE COS. METHODS: Four breakout groups at the SLE SIG in Colorado Springs winnowed and binned 132 domain sub-themes into candidate domains, which was continued with a series of virtual meetings by an advisory group of SLE patient research partners (PRPs), members of the OMERACT SLE Working Group Steering Committee, and other collaborators. RESULTS: The 132 domain sub-themes were reduced to a preliminary list of 20 candidate domains based on their clinical and research relevance for clinical trials and research studies. CONCLUSION: A meaningful and substantial winnowing and binning of candidate domains for the SLE COS was achieved resulting in a preliminary list of 20 candidate domains.
引用
- Nielsen W, Strand V, Simon LS, et al. OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set. Semin Arthritis Rheum. 2024. PMID: 38281467. doi:10.1016/j.semarthrit.2024.152380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。